Source: Annual Congress 2005 - Cystic fibrosis: genes, inflammation and more
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Norbedo, I. Giuseppin, T. Gerarduzzi, F. Poli (Trieste, Italy). The role of MBL in B. cepacia infections in CF patients. Eur Respir J 2005; 26: Suppl. 49, 2573

Member's Comments

No comment yet.

Related content which might interest you: Burkholderia cepacia complex infection in Czech patients with cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 503s Year: 2003 Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients Source: Eur Respir J 2004; 23: 851-856 Year: 2004 Burkholderia cepacia infection in adult cystic fibrosis patients: Its impact on lung function and survival Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 TNF and LTA gene polymorphisms in cystic fibrosis patients with Burkholderia cepacia complex (Bcc) Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis Year: 2021 The relevance of epidemic ET-12 B. cenocepacia lipopolysaccharide (LPS) structure and cytokine induction capacity compared to other burkholderia cepacia complex species Source: Eur Respir J 2006; 28: Suppl. 50, 485s Year: 2006 Treatment of Burholderia cepacia infection in patients with cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 539s Year: 2001 Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD. Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020 Phenotypic assessment of potential Burkholderia cepacia virulence associated determinants Source: Eur Respir J 2003; 22: Suppl. 45, 503s Year: 2003 Nebulized heparin in Burkholderia cepacia colonized adult cystic fibrosis patients Source: Eur Respir J 2001; 17: 36-38 Year: 2001 Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis Source: Virtual Congress 2021 – Back to infection basics Year: 2021 Changes in local and systemic inflammatory markers in cystic fibrosis patients chronically infected with Burkholderia cepacia complex Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020 Prevalence of pseudomonas aeruginosa in pancreatic sufficient CF patients in Scandinavia Source: Eur Respir J 2006; 28: Suppl. 50, 714s Year: 2006 Characterization of the resistance mechanisms to carbapenems and virulence genes in Pseudomonas aeruginosa strains from children with cystic fibrosis. Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 The impact of testosterone on Pseudomonas aeruginosa pathogenicity and antimicrobial susceptibility Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 The role of efflux pump systems and OprD porine in antimicrobial resistance of Pseudomonas aeruginosa strains isolated from patients with bronchiectasis Source: Virtual Congress 2021 – Back to infection basics Year: 2021 Detection of Pseudomonas aeruginosa infection in cystic fibrosis patients by eNose technology Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis Source: Eur Respir J, 51 (2) 1701953; 10.1183/13993003.01953-2017 Year: 2018 Cystic fibrosis infection with clonal strains of Pseudomonas aeruginosa: current knowledge and future management Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=105 Year: 2006 Clinical and microbiological characteristics of Pseudomonas aeruginosa isolates from patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 58s Year: 2005